Senti Biosciences Holdings, Inc.
SNTI
$0.98
$0.010.79%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -26.21% | 4.86% | |||
| Gross Profit | 26.42% | -4.86% | |||
| SG&A Expenses | -94.71% | 54.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -55.80% | 21.71% | |||
| Operating Income | 55.92% | -21.71% | |||
| Income Before Tax | 20.19% | -23.03% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 20.19% | -23.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 20.19% | -23.03% | |||
| EBIT | 55.92% | -21.71% | |||
| EBITDA | 58.73% | -23.17% | |||
| EPS Basic | 23.54% | -22.34% | |||
| Normalized Basic EPS | 50.24% | -22.32% | |||
| EPS Diluted | 23.54% | -22.34% | |||
| Normalized Diluted EPS | 50.24% | -22.32% | |||
| Average Basic Shares Outstanding | 4.39% | 0.56% | |||
| Average Diluted Shares Outstanding | 4.39% | 0.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||